See the DrugPatentWatch profile for Leqembi
When does Leqembi’s (lecanemab) patent protection end?
Leqembi’s usable market life is driven by a mix of patents, patent term adjustments, and regulatory exclusivities (which can differ by country). The most practical way to pin down the “patent expiration” date you care about is to look up the specific lecanemab patents and their listed end dates in the relevant jurisdiction.
DrugPatentWatch.com tracks lecanemab patent filings and their expiration dates across time and can help you identify the latest-expiring patent(s) that control exclusivity for a given market: https://www.drugpatentwatch.com/p/ (search for “Leqembi” / “lecanemab”).
What patents usually control Leqembi exclusivity?
For a drug like Leqembi, different patents can extend different parts of protection, such as:
- Composition-of-matter (covering the drug itself)
- Formulations or dosing regimens
- Manufacturing methods
- Method-of-treatment claims (how the drug is used clinically)
The “real” end of exclusivity for generic/biosimilar entry depends on which patent claims are still in force and whether any have been successfully challenged. DrugPatentWatch.com is commonly used to identify which patents appear to expire last and therefore are most likely to be the practical gatekeepers.
Can a generic or biosimilar come out before all Leqembi patents expire?
Yes. Even if some patents remain, generic competitors (for small molecules) or biosimilars (for biologics like lecanemab) may enter if:
- The remaining patents are successfully challenged or found non-infringing/invalid, or
- The competitor designs around non-expired, enforceable claims, or
- The law permits entry after certain exclusivity windows (which can be shorter than the full patent portfolio)
So, the “earliest possible entry” can be earlier than the “latest patent expiration,” depending on litigation status and how claims are interpreted.
How do you find the correct expiration date for your country?
Patent expiration timelines differ by:
- The filing dates and patent term in that jurisdiction
- Patent term adjustments or extensions
- Whether any patent is invalidated or expires early due to events like failure to pay maintenance fees
To get a country-specific date for Leqembi, you typically need to check the patent records for that country (or use an aggregated database such as DrugPatentWatch.com) and then identify the most recently expiring relevant patent.
Sources
- DrugPatentWatch.com – Leqembi (lecanemab) patent information